Return to homepagePandemic Pact

Development of Population Level Serotyping Technology and Antibody Profiling for Infectious Pathogens with focus on Influenza and SARS-CoV-2

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3R44CA203629-03S1

Grant search

Key facts

  • Disease

    COVID-19, Unspecified

  • Start & end year

    2016
    2021

  • Known Financial Commitments (USD)

    $728,518

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    Kevin L Gunderson

  • Research Location

    United States of America

  • Lead Research Institution

    Encodia Inc

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Abstract: The goal of this proposal is to repurpose technology developed for Next-GenProteomics to develop a highly-scalable digital serotyping technology for infectiousdisease analysis, with particular application to influenza and Covid-19. The approach isbroadly applicable and should greatly improve upon cost, sensitivity, usability, andthroughput of population-level serotyping and greatly improve infectious diseasemonitoring and surveillance.